PHIO PHARMACEUTICALS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-03-31 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-12-31 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2017-09-30 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 0.00 shares 10-K · filed 2026-03-05 |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-05 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-10 | 0.00 shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-26 | 0.00 shares 10-K · filed 2018-03-26 |
| 2017-09-30 | 0.00 shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-03-26 | 0.00 shares derived: sum of 4 quarters · filed 2018-03-26 |
| 2017-06-30 | 0.00 shares derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-03-26 | 0.00 shares derived: sum of 4 quarters · filed 2018-03-26 |
| 2017-03-31 | 0.00 shares 10-Q/A · filed 2018-03-26 | 0.00 shares derived: sum of 4 quarters · filed 2018-03-26 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | 0.00 shares 10-K · filed 2017-03-30 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 0.00 shares derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-12 | 0.00 shares derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 0.00 shares 10-K · filed 2016-03-30 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-13 | |
| 2014-12-31 | 0.00 shares 10-K · filed 2015-03-30 | |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | 2.00K shares 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |